These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis. Xu SX; Shen JL; Tang XF; Feng B; Xu HQ Eur Rev Med Pharmacol Sci; 2016; 20(2):381-90. PubMed ID: 26875911 [TBL] [Abstract][Full Text] [Related]
6. Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients. Playford EG; Webster AC; Sorrell TC; Craig JC Eur J Clin Microbiol Infect Dis; 2006 Sep; 25(9):549-61. PubMed ID: 16912905 [TBL] [Abstract][Full Text] [Related]
7. Choosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis. Wang Y; Xie J; Xing Y; Chen L; Li Y; Meng T; Dong W; Wang X; Dong Y Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993334 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs. Wang JF; Xue Y; Zhu XB; Fan H Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):651-9. PubMed ID: 25502737 [TBL] [Abstract][Full Text] [Related]
9. Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis. Gatti M; Rinaldi M; Ferraro G; Toschi A; Caroccia N; Arbizzani F; Raschi E; Poluzzi E; Pea F; Viale P; Giannella M Mycoses; 2021 Nov; 64(11):1317-1327. PubMed ID: 34387004 [TBL] [Abstract][Full Text] [Related]
10. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis. Ziakas PD; Kourbeti IS; Mylonakis E Clin Ther; 2014 Feb; 36(2):292-306.e1. PubMed ID: 24439393 [TBL] [Abstract][Full Text] [Related]
11. Antifungal prophylaxis in liver transplant recipients: one size does not fit all. Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076 [TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients. Winston DJ; Busuttil RW Transplantation; 2002 Sep; 74(5):688-95. PubMed ID: 12352887 [TBL] [Abstract][Full Text] [Related]
13. A Multicenter, Randomized, Open-Label Study to Compare Micafungin with Fluconazole in the Prophylaxis of Invasive Fungal Infections in Living-Donor Liver Transplant Recipients. Kang WH; Song GW; Lee SG; Suh KS; Lee KW; Yi NJ; Joh JW; Kwon CHD; Kim JM; Choi DL; Kim JD; Kim MS J Gastrointest Surg; 2020 Apr; 24(4):832-840. PubMed ID: 31066013 [TBL] [Abstract][Full Text] [Related]
14. Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis. Fortún J; Muriel A; Martín-Dávila P; Montejo M; Len O; Torre-Cisneros J; Carratalá J; Muñoz P; Fariñas C; Moreno A; Fresco G; Goikoetxea J; Gavaldá J; Pozo JC; Bodro M; Vena A; Casafont F; Cervera C; Silva JT; Aguado JM; Liver Transpl; 2016 Apr; 22(4):427-35. PubMed ID: 26709146 [TBL] [Abstract][Full Text] [Related]
16. Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients. Saliba F; Pascher A; Cointault O; Laterre PF; Cervera C; De Waele JJ; Cillo U; Langer RM; Lugano M; Göran-Ericzon B; Phillips S; Tweddle L; Karas A; Brown M; Fischer L; ; Clin Infect Dis; 2015 Apr; 60(7):997-1006. PubMed ID: 25520332 [TBL] [Abstract][Full Text] [Related]
17. Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review. Pechlivanoglou P; Le HH; Daenen S; Snowden JA; Postma MJ J Antimicrob Chemother; 2014 Jan; 69(1):1-11. PubMed ID: 23975736 [TBL] [Abstract][Full Text] [Related]
18. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience. Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052 [TBL] [Abstract][Full Text] [Related]
19. Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study. Rinaldi M; Bartoletti M; Ferrarese A; Franceschini E; Campoli C; Coladonato S; Pascale R; Tedeschi S; Gatti M; Cricca M; Ambretti S; Siniscalchi A; Morelli MC; Cescon M; Cillo U; Di Benedetto F; Burra P; Mussini C; Cristini F; Lewis R; Viale P; Giannella M Transpl Infect Dis; 2021 Aug; 23(4):e13608. PubMed ID: 33768656 [TBL] [Abstract][Full Text] [Related]
20. Prophylaxis with itraconazole is more effective than prophylaxis with fluconazole in neutropenic patients with hematological malignancies: a meta-analysis of randomized-controlled trials. Wang J; Zhan P; Zhou R; Xu J; Shao X; Yang Y; Ouyang J Med Oncol; 2010 Dec; 27(4):1082-8. PubMed ID: 19876778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]